Insider Transactions: Meta, CrowdStrike CEOs Sell Stock; Executives Buy into REITs and Biotechs

Recent regulatory filings reveal a wave of insider trading activity across U.S. public companies, highlighted by substantial stock sales from chief executives at major technology firms and notable open-market purchases by insiders at several real estate and biotechnology companies.

Top Executives Sell Shares

Several high-profile executives sold large blocks of stock, with most transactions executed under pre-arranged Rule 10b5-1 trading plans. These plans allow insiders to schedule transactions in advance to avoid accusations of trading on non-public information.

• Meta Platforms (NASDAQ:META): Chairman and CEO Mark Zuckerberg sold shares totaling approximately $21.36 million on September 24 through affiliated entities.
• Gitlab (NASDAQ:GTLB): Director Sytse Sijbrandij conducted the largest sale, disposing of shares worth approximately $101.1 million between September 24 and September 28.
• CrowdStrike (NASDAQ:CRWD): President and CEO George Kurtz sold 20,000 shares for a total of $5.16 million on September 24 and 25.
• Duolingo (NASDAQ:DUOL): President and CEO Luis von Ahn sold shares valued at approximately $4.25 million on September 16.

These sales occurred as many of the companies' stocks, including Meta and CrowdStrike, traded near their 52-week highs following significant gains over the past year. The use of 10b5-1 plans suggests these sales were predetermined and may be part of personal financial management or diversification strategies rather than a reaction to current market conditions.

Insiders Make Significant Buys

Ad

In contrast, several executives and directors made substantial stock purchases on the open market, a move often interpreted by investors as a signal of confidence in their company's future prospects.

• Inhibrx Biosciences (NASDAQ:INBX): CEO and Director Mark Lappe acquired common stock worth $998,783 across multiple transactions on September 25 and 28.
• Redwood Trust (NYSE:RWT): CEO Christopher J. Abate purchased 100,000 shares for $383,900 on September 15, as the stock trades down 25% over the past year.
• INFINITY NATURAL RESOURCES (NASDAQ:INR): EVP and CFO Cary D. Baetz bought 22,316 shares for a total of $299,993 in late September.
• Angel Oak Mortgage REIT (NASDAQ:AOMR): Director Michael Fierman acquired 38,726 shares for $290,510 on September 25, with the stock trading near its 52-week low.
• Damora Therapeutics (NASDAQ:DMRA): CEO Jennifer Jarrett purchased 12,500 shares for $252,875 on September 25.

What This Means for Investors

Monitoring insider transactions can provide valuable context for investment analysis. While significant open-market purchases can indicate strong internal belief in a company's valuation and outlook, insider sales are often more difficult to interpret. Insiders may sell shares for numerous reasons unrelated to company performance, including portfolio diversification, tax planning, or personal liquidity needs.

Investors typically view insider sales conducted under 10b5-1 plans as less significant than spontaneous sales. Ultimately, insider activity should be considered as one of many data points in a comprehensive investment thesis, not as a standalone trading signal.